Hyundai Bioscience will begin a clinical trial with Seoul National University Hospital to identify the cause of drug resistance raised during prostate cancer treatment. Hyundai Bioscience said on the ...

A study conducted by doctors and occupational sociologists at the Avignon Hospital Center on over 500 lymphoma patients found ...

URO-1, a Greensboro medical device company specialized in prostate and soft tissue cancer diagnostics, is expanding its ...

Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...

Jerry McCormick’s path to recover from prostate cancer has been anything but linear. Documenting progress and setbacks helps ...

For prostate biopsy planning, multiparametric MRI has relatively low specificity particularly for PI-RADS 3 and PI-RADS 4 ...

Market OverviewThe global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period.

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

NHS England has given the green light for abiraterone to be used to treat men with prostate cancer that has not metastasised. It is the first time the drug will be available for these patients in ...

For years, the Blue Jacket Fashion Show has invited stars to walk NYFW runways to raise awareness for prostate cancer.

For people who are at high risk of developing breast cancer, frequent screenings with ultrasound can help detect tumors early ...